Intratumoral Injection of Autologous CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Talimogene Laherparepvec (T-VEC)
Clinical trial NCT03747744 · UNKNOWN
Trial details
- NCT number
- NCT03747744
- Sponsor
- Universitair Ziekenhuis Brussel
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-28
- Primary completion
- 2023-10-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.